Saint Vincent and the Grenadines Formally Recognizes the Indian Pharmacopoeia, Expanding Global Healthcare Collaboration
In a landmark development for global health diplomacy, India,Saint Vincent and the Grenadines have officially signed a Memorandum of Understanding (MoU) for the formal recognition of...
New Hope for Thyroid Eye Disease Treatment as FDA Approves Lumvoa
Waltham-based Viridian Therapeutics (Nasdaq: VRDN) has secured U.S. Food and Drug Administration clearance for Lumvoa™ (veligrotug-vvze), marking the company's debut as a commercial-stage biotech and...
Novartis strikes a $1.9B partnership with Antares Therapeutics to tackle “undruggable” cancer targets.
Novartis has entered into a strategic collaboration and license agreement with Antares Therapeutics to discover and develop next-generation small molecule oncology treatments. The transaction...
Trodelvy Approved in Europe for Hard-to-Treat Breast Cancer Patients
The European Commission has granted marketing authorization for Trodelvy® (sacituzumabgovitecan) as an initial treatment for adults with unresectable or metastatic triple-negative breast cancer (mTNBC) who are ineligible...
Novaspire Biosciences and Abhinavayan Biotech Announce Strategic Leadership and Core Partnership
Novaspire Biosciences, a premier clinical research organization, announced a strategic evolution in its leadership and ownership structure through a core partnership with Abhinavayan Biotech. This collaboration marks...
FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.
A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
